4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-049065
Chief Medical Officer sold 2,000 shares at an average $80.03 ($160,051)
- Chief Medical Officer acquired 2,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bowden Christopher Chief Medical Officer | 2018-08-29 | Option exercise | +300 | $35.16 | $10,548 | 1,224 | D |
| Bowden Christopher Chief Medical Officer | 2018-08-29 | Sale | −300 | $80.00 | $24,000 | 924 | D |
| Bowden Christopher Chief Medical Officer | 2018-08-30 | Option exercise | +1,700 | $35.16 | $59,772 | 2,624 | D |
| Bowden Christopher Chief Medical Officer | 2018-08-30 | Sale | −1,700 | $80.03 | $136,051 | 924 | D |
| Derivatives | |||||||
| Bowden Christopher Chief Medical Officer | 2018-08-29 | Option exercise · Stock option (right to buy) | −300 | 92,700 | D | ||
| Bowden Christopher Chief Medical Officer | 2018-08-30 | Option exercise · Stock option (right to buy) | −1,700 | 91,000 | D | ||
| Open-market sales · 2,000 sh · avg $80.03 · $160,051 | |||||||
Loading xslF345X03/doc4.xml…